# A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744

> **NCT00659191** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 58 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** GSK1265744

## Key facts

- **NCT ID:** NCT00659191
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2010-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00659191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00659191, "A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00659191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*